Arexvy (RSV vaccine) is a FDA-approved vaccine used to lower the risk of illness caused by respiratory syncytial virus (RSV). It's the first RSV vaccine approved in the United States. You can receive Arexvy (RSV vaccine) if you're age 60 years or older, and in some cases, starting at age 50 if you're at high risk for serious problems if infected. But first, you should discuss the risks and benefits with your primary care provider. Arexvy (RSV vaccine) is given once as a shot into the muscle, typically in your upper arm. Common side effects of this vaccine include injection site reactions, headache, joint and muscle aches, and feeling tired.
Prevention of illness caused by respiratory syncytial virus (RSV)
Arexvy (RSV vaccine) is an recombinant subunit vaccine. Pieces of RSV are put into the vaccine. Once inside your body, these pieces of RSV triggers the immune system to make proteins called antibodies against RSV. These antibodies will help prevent infection by attacking the virus if it ever infects your body.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Given as a single dose
Lowers risk of RSV-related illness by about 83% in people 60 years and older
One shot gives protection over 2 RSV seasons
Not approved for use in people under 50 years old
Can cause unpleasant side effects, like muscle aches, tiredness, and headache
Can only be given as an injection into the muscle by a healthcare professional
Read the vaccine information statement for more information about Arexvy (RSV vaccine).
Talk to your healthcare professional (HCP) about your vaccine history, so they can make sure you're up to date with all of your vaccines.
After receiving Arexvy (RSV vaccine), it can be helpful to stay seated for a while. Injectable vaccines like Arexvy (RSV vaccine) can sometimes cause fainting.
It's common to experience feeling tired, headache, muscle aches, and joint pain after your vaccination with Arexvy (RSV vaccine). These side effects should go away after a few days. If they don't or get worse, contact your HCP.
Arexvy (RSV vaccine) doesn't contain preservatives, and isn't made with latex. However, you should tell your HCP all of your allergies before getting Arexvy (RSV vaccine) so they can make sure it's safe for you.
Arexvy (RSV vaccine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Although rare, it's possible for Arexvy (RSV vaccine) to cause a severe allergic reaction. Get medical help right away if you experience tightness in your chest, trouble breathing, skin rash, or swelling in your lips, tongue, throat, or face after receiving Arexvy (RSV vaccine).
Some people feel faint after getting injectable vaccines like Arexvy (RSV vaccine). Stay seated for a while after getting your vaccine, and stand up slowly to make sure you don't fall if you suddenly feel faint.
Risk factors: Medical conditions that weaken the immune system | Taking medications that weaken your immune system
Arexvy (RSV vaccine) might not work as well in people with a weakened immune system. If you have any medical conditions (e.g., human immunodeficiency virus or HIV, cancer) or take medications that weaken your immune system (e.g., high-dose corticosteroids, transplant medications, cancer medications), talk to your primary care provider first before getting Arexvy (RSV vaccine).
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
1 dose | 1 carton | $314.80 | $314.80 |
The typical dose is 0.5 mL injected into the muscle by a healthcare professional.
Prevention of illness caused by respiratory syncytial virus (RSV)
Adults ages 60 years and older
Pregnant females between 32 to 36 weeks of pregnancy
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Centers for Disease Control and Prevention. (2024). Healthcare Providers: RSV Vaccination for Adults 60 Years of Age and Over.
Centers for Disease Control and Prevention. (2020). Fainting (syncope) after vaccination.
Centers for Disease Control and Prevention. (2022). People at high risk for severe RSV infection.
Centers for Disease Control and Prevention. (2023). Respiratory syncytial virus infection (RSV) - For healthcare providers.
Centers for Disease Control and Prevention. (2024). Frequently Asked Questions About RSV Vaccine for Adults.
Centers for Disease Control and Prevention. (2024). Respiratory Syncytial Virus Infection (RSV)
Centers for Disease Control and Prevention. (2024). RSV in older adults and adults with chronic medical conditions.
GlaxoSmithKline Biologicals SA. (2023). Arexvy- respiratory syncytial visus vaccine recombinant, adjuvanted kit [package insert]. DailyMed.
U.S. Department of Health and Human Services. (2022). Vaccine types.
U.S. Food & Drug Administration. (2023). FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine.
World Health Organization. (2020). How do vaccines work?
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.